Inactive Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14)

The purpose of this amendment is to make clarifications to the statement of work and extend the solicitation. The language in part 2.0 Background of Statement of Work has been revised. Changes can be ... The purpose of this amendment is to make clarifications to the statement of work and extend the solicitation. The language in part 2.0 Background of Statement of Work has been revised. Changes can be found in the SOW below. The solicitation s due date for quotes is extended from 02/09/2024 at 12PM MST, to 02/12/2024 at 5PM MST. Statement of Work Department of Veterans Affairs Veterans Health Administration Eastern Oklahoma VA Health Care System Drug Database Subscription General Information 1.0 Introduction: The Department of Veterans Affairs (DVA), Veterans Health Administration (VHA), Eastern Oklahoma VA Health Care System(EOVAHCS) requires online access to a commercial, off-the-shelf, drug database subscription (DDB) that will be made available throughout the health care system. This database will serve to assist health care providers in their clinical decision making and drug information needs at the point of care. 2.0 Background: a. The EOVAHCS, which includes the Jack C. Montgomery VA Medical Center and affiliated Community Based Outpatient Clinics, requires online web access to searchable medical and drug references for retrieval of current, authoritative, and evidence-based medical and drug information for health care providers and patients. b. Electronic medical references reduce the need for multiple individual hard copies of expensive print resources and allow for cross searching multiple clinical information resources. This method provides a more efficient manner of retrieving medically necessary information to meet the clinical mission of providing quality care to Veterans within the EOVAHCS Network. c. Health care providers need these online tools to be available on VA networked and non-VA networked computers, both onsite and offsite, as well as on mobile devices, to have health information available to provide care for patients. d. This resource must provide patient health information that is printable and suitable in reading level and content for Veteran patients and their families, that can be provided to Veteran patients, their family members and caregivers. e. The DDB Database is to be used in the manner of a point of care online resource tool. 3.0 Scope of Work: a. The contractor shall provide all resources necessary to meet the requirements described in this statement of work for an online, commercial, off-the-shelf, drug database subscription (DDB). b. The contractor shall provide 24/7, simultaneous-user, online web access to the DDB subscription as stated herein for staff at facilities in the EOVAHCS (via IP), to their mobile devices (via Apps or mobile websites), or to their remote work areas. Remote access must include access via an offsite access system (such as LibLynx), and mobile platforms including various popular hand-held devices, for all healthcare providers across the Department of Veterans Affairs (DVA). c. Monthly usage reports shall be provided. d. Updates to the DDB shall be included automatically with no additional cost. 4.0 Performance Period: One (1) year from date of award, plus four (4) one (1) year option periods to be exercised at the discretion of the Government. 5.0 Required DDB Subscription Requirements and Salient Characteristics: The contractor shall provide a DDB Subscription which addresses the following requirements and salient characteristics: a) Provides up-to-date drug information [prescription, over the counter (OTC), alternative medicine]; b) Determines dosing, side effects/adverse events, and interactions, both drug-drug and drug-food; drug-OTC, drug-alternative medicine c) Provides full-text databases on chemical, pharmaceutical, and related biological substances used in clinical patient care; d) Includes drug reviews, guidelines, clinical reviews, and information from package inserts and drug texts; e) Contains clinical calculators f) Provides access to Black-Box warnings; g) Provides drug formulary information; h) Contains a clinical teaching section to assist in communicating information to patients; i) Provides comparison tables to compare drugs within a class for features like half-life or other valuable information; j) Comprehensive medication monographs which include information regarding FDA and non-FDA indications, with literature citations for the evidence base; k) Summaries of clinically relevant primary literature within the resource (more than just a reference to a source; l) Provide primary literature references and summary data in the resource for comparative efficacy and off-label indications; m) Contain references to abstracts, tertiary electronic sources and full text articles; n) Provide a uniform search tool and user interface throughout the product; o) Updated on a daily basis by a review board of allied health professionals; contains a date of last review/update for each section; p) Provides content on acute care, alternative medicine, drug information, toxicology, teratogenic medications, patient education, and occupational health and safety including material safety data sheets; q) Ability to "brand" both web and printed materials with practice site logos and contact information; r) Provide drug assessments to the user based on manufacturer monographs and peer reviews of primary literature; s) Provide references to primary literature to support recommendations and/or indications for therapy. t) Provides side-by-side comparative drug evaluations with primary literature summaries to allow time effective comparison of more than one agent with one search. Includes concise reviews of trials or case reports including key characteristics of study design such (number of patients, p-values, population included); u) Provide users with a multitude of web-based calculators designed to meet the needs of all healthcare providers; v) Comprehensive information available about drug use in special populations including renal impairment, hepatic impairment, geriatrics, dialysis, obesity and other relevant disease states that will vary by drug; w) Provide consumer appropriate printable health information on medications, procedures, and disease states. This health information should be available in at least English and Spanish languages; x) Provide a drug interaction tool that can enter multiple drugs and allergies for a given patient with output of entry that includes drug-drug, drug-allergy, drug-ethanol, drug-lab, drug-food, drug-tobacco, drug-pregnancy and drug-lactation interactions; y) Drug Interaction tool will provide severity of interaction; Adverse drug reactions will include percentages of patients affected by the interaction where available and include case reports; z) Provide a tool for medication identification based on any information available to the provider (i.e. color, imprint, formulation, etc.); aa) Provide administration with tracking tools to include stats on particular components used by the organization; bb) Exportable to an iPhone, blackberry, iPad or android device for point of care decisions; cc) Provide an IV compatibility database that is comprehensive, searchable, and which may be drilled to obtain more information or references; dd) Provide pharmacy compounding stability information; ee) Components of the clinical topic review for drug information shall include the following fields: a. Medical Safety Issues/Alerts. b. Brand Names. c. Pharmacologic Category. d. Dosing (Adults, Elderly, Pediatric, etc.) and Forms (capsule, tablet, liquid, etc.). e. Generic Alternative availability. f. Administration, Use, Contraindications, Warnings/Precautions. g. Specific Populations (Pregnancy Risk Factor/Lactation/Breast Feeding, Pediatric, Geriatric, etc.). h. Dietary Considerations. i. Mechanism of Action. j. Metabolism/Interactions. k. Pharmacodynamics/Kinetics. l. References section. m. Graphics (figures, pictures, graphics, tables, etc.) integrated into record/review that can be printed or exported. n. Hyperlinks to related record/review topics. ff) The contractor shall provide users an intuitive navigation interface for searching, navigating, and reading through database content and the results of a database search; and, gg) Poison control information including antidote and supportive care recommendations. 6.0 Users shall be able to: 1. Enter a search phrase consisting of one or more terms or select a term from drop down menu of potential matches after typing the first few characters of the term. 2. Enter names of diseases, symptoms, laboratory abnormalities, procedures, drugs, classes of drugs, etc. to retrieve topical reviews. 3. Enter common synonyms, abbreviations, and acronyms that will be mapped to the appropriate topical review(s) in display results. 4. Search for drug information and retrieve topic reviews containing information about the drug. 5. Search for drug information by retrieving the drug record. 6. Search for drug interactions by entering drug name to display a complete list of interactions for the drug. 7. Choose and use medical specialty calculators interactively by entering required values/units of information to determine mathematical calculation. 8. Sort search results for display through the use of categorization options such as adult, pediatric, etc. 9. Find specific text within a topic review using the product s find tool. 10. Select among various output options, including printing all or selected portions of the topical review 7.0 Additional Customer Support Requirements: a. A single point of contact for customer service issues is named, available by both phone and email, and assigned to LNO Program Manager or its representative. At least one alternative contact is provided for absences of the provided single point of contact. A single point of contact shall be supplied for the database, and shall follow all of the following terms: b. The single point of contact should be available via telephone and email during normal business hours and should not have excessive business travel or all day training commitments. Any scheduled out of office time must be notified to the LNO Program Manager with a minimum of two (2) week notice. c. The LNO Program Manager reserves the right to request and be provided a replacement single point of contact representative within 60 days after request. This request can be made for any reason or no reason at all, with no additional cost necessary or reason provided. The number of these requests is made at the discretion of the LNO Program Manager. d. It is the responsibility of the VA specified customer service contact to be fully educated and familiar with the physical and administrative structure of the VA system. e. The contractor shall provide monthly reports to the LNO Program Manager of technical service requests provided to VA customers. The contractor s point of contact shall meet with the LNO Program Manager via conference call to review reports (date/time/frequency TBD). f. Each report shall provide at a minimum the following columns in Excel format with: 1. Reference #. 2. Date Created. 3. First Assigned Technical Service Representative. 4. Customer Full Name. 5. Email Address of customer. 6. Issue/Request Statement. 7. Status. 8. Result. 9. Other information per Contractor choice.